<page><title>SYNGAP1-related intellectual disability</title><url>https://medlineplus.gov/genetics/condition/syngap1-related-intellectual-disability</url><content>SYNGAP1-related intellectual disability
To use the sharing features on this page, please enable JavaScript.
Description
SYNGAP1
-related intellectual disability is a neurological disorder characterized by moderate to severe intellectual disability that is evident in early childhood. The earliest features are typically delayed development of speech and motor skills, such as sitting, standing, and walking. Many people with this condition have weak muscle tone (hypotonia), which contributes to the difficulty with motor skills. Some affected individuals lose skills they had already acquired (developmental regression). Other features of
SYNGAP1
-related intellectual disability include recurrent seizures (epilepsy), hyperactivity, and
autism spectrum disorder
, which is characterized by impaired communication and social interaction; almost everyone with
SYNGAP1
-related intellectual disability develops epilepsy, and about half have autism spectrum disorder.
Frequency
SYNGAP1
-related intellectual disability is a relatively common form of cognitive impairment. It is estimated to account for 1 to 2 percent of intellectual disability cases.
Causes
SYNGAP1
-related intellectual disability is caused by mutations in the
SYNGAP1
gene. The protein produced from this gene, called SynGAP, plays an important role in nerve cells in the brain. It is found at the junctions between nerve cells (
synapses
) and helps regulate changes in synapses that are critical for learning and memory. Mutations involved in this condition prevent the production of functional SynGAP protein from one copy of the gene, reducing the protein's activity in cells. Studies show that a reduction of SynGAP activity can have multiple effects in nerve cells, including pushing synapses to develop too early. The resulting abnormalities disrupt the synaptic changes in the brain that underlie learning and memory, leading to cognitive impairment and other neurological problems characteristic of
SYNGAP1
-related intellectual disability.
Learn more about the gene associated with SYNGAP1-related intellectual disability
SYNGAP1
Inheritance
SYNGAP1
-related intellectual disability is classified as an autosomal dominant condition, which means one copy of the altered gene in each cell is sufficient to cause the disorder. Almost all cases result from
new mutations in the gene
and occur in people with no history of the disorder in their family. In at least one case, an affected person inherited the mutation from
one affected parent
.
Other Names for This Condition
Mental retardation, autosomal dominant 5
MRD5
Additional Information &amp; Resources
Genetic Testing Information
Genetic Testing Registry: Intellectual disability, autosomal dominant 5
Genetic and Rare Diseases Information Center
Intellectual developmental disorder, autosomal dominant 5
Patient Support and Advocacy Resources
National Organization for Rare Disorders (NORD)
Clinical Trials
ClinicalTrials.gov
Catalog of Genes and Diseases from OMIM
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 5; MRD5
Scientific Articles on PubMed
PubMed
References
Aceti M, Creson TK, Vaissiere T, Rojas C, Huang WC, Wang YX, Petralia RS, Page
DT, Miller CA, Rumbaugh G. Syngap1 haploinsufficiency damages a postnatal
critical period of pyramidal cell structural maturation linked to cortical
circuit assembly. Biol Psychiatry. 2015 May 1;77(9):805-15. doi:
10.1016/j.biopsych.2014.08.001. Epub 2014 Aug 13.
Citation on PubMed
or
Free article on PubMed Central
Clement JP, Aceti M, Creson TK, Ozkan ED, Shi Y, Reish NJ, Almonte AG, Miller
BH, Wiltgen BJ, Miller CA, Xu X, Rumbaugh G. Pathogenic SYNGAP1 mutations impair
cognitive development by disrupting maturation of dendritic spine synapses. Cell.
2012 Nov 9;151(4):709-723. doi: 10.1016/j.cell.2012.08.045.
Citation on PubMed
or
Free article on PubMed Central
Clement JP, Ozkan ED, Aceti M, Miller CA, Rumbaugh G. SYNGAP1 links the
maturation rate of excitatory synapses to the duration of critical-period
synaptic plasticity. J Neurosci. 2013 Jun 19;33(25):10447-52. doi:
10.1523/JNEUROSCI.0765-13.2013.
Citation on PubMed
or
Free article on PubMed Central
Mignot C, von Stulpnagel C, Nava C, Ville D, Sanlaville D, Lesca G, Rastetter
A, Gachet B, Marie Y, Korenke GC, Borggraefe I, Hoffmann-Zacharska D, Szczepanik
E, Rudzka-Dybala M, Yis U, Caglayan H, Isapof A, Marey I, Panagiotakaki E, Korff
C, Rossier E, Riess A, Beck-Woedl S, Rauch A, Zweier C, Hoyer J, Reis A, Mironov
M, Bobylova M, Mukhin K, Hernandez-Hernandez L, Maher B, Sisodiya S, Kuhn M,
Glaeser D, Weckhuysen S, Myers CT, Mefford HC, Hortnagel K, Biskup S;
EuroEPINOMICS-RES MAE working group; Lemke JR, Heron D, Kluger G, Depienne C.
Genetic and neurodevelopmental spectrum of SYNGAP1-associated intellectual
disability and epilepsy. J Med Genet. 2016 Aug;53(8):511-22. doi:
10.1136/jmedgenet-2015-103451. Epub 2016 Mar 17. Erratum In: J Med Genet. 2016
Oct;53(10):720. doi: 10.1136/jmedgenet-2015-103451corr1.
Citation on PubMed
Ozkan ED, Creson TK, Kramar EA, Rojas C, Seese RR, Babyan AH, Shi Y, Lucero R,
Xu X, Noebels JL, Miller CA, Lynch G, Rumbaugh G. Reduced cognition in Syngap1
mutants is caused by isolated damage within developing forebrain excitatory
neurons. Neuron. 2014 Jun 18;82(6):1317-33. doi: 10.1016/j.neuron.2014.05.015.
Citation on PubMed
or
Free article on PubMed Central
Parker MJ, Fryer AE, Shears DJ, Lachlan KL, McKee SA, Magee AC, Mohammed S,
Vasudevan PC, Park SM, Benoit V, Lederer D, Maystadt I, Study D, FitzPatrick DR.
De novo, heterozygous, loss-of-function mutations in SYNGAP1 cause a syndromic
form of intellectual disability. Am J Med Genet A. 2015 Oct;167A(10):2231-7. doi:
10.1002/ajmg.a.37189. Epub 2015 Jun 15.
Citation on PubMed
or
Free article on PubMed Central
Wang CC, Held RG, Hall BJ. SynGAP regulates protein synthesis and homeostatic
synaptic plasticity in developing cortical networks. PLoS One. 2013 Dec
31;8(12):e83941. doi: 10.1371/journal.pone.0083941. eCollection 2013.
Citation on PubMed
or
Free article on PubMed Central
The information on this site should not be used as a substitute for professional medical care or advice. Contact a health care provider if you have questions about your health.
Official websites use .gov
A
.gov
website belongs to an official government
              organization in the United States.
Secure .gov websites use HTTPS
A
lock
(
Lock
Locked padlock icon
) or
https://
means youâ€™ve safely connected to
              the .gov website. Share sensitive information only on official,
              secure websites.</content></page>